| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $167K | -15.7% | -60.9% |
| Cost of Revenue | $111K | -0.9% | -61.9% |
| Gross Profit | $56K | -34.9% | -58.8% |
| R&D Expense | $4.0M | +3.6% | +30.2% |
| SG&A Expense | $2.6M | -4.9% | +5.5% |
| Operating Income | -$6.5M | -0.5% | -21.0% |
| Pre-tax Income | -$6.2M | +10.2% | +2.4% |
| Income Tax | -$8K | +0.0% | — |
| Net Income | -$5.5M | +15.2% | +9.7% |
| EPS (Basic) | -$0.55 | +22.5% | +41.5% |
| EPS (Diluted) | -$0.55 | +22.5% | +41.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.4M | -27.1% | -59.8% |
| Current Assets | $10.5M | -24.2% | -61.9% |
| Total Assets | $26.1M | -14.8% | -30.3% |
| Current Liabilities | $32.0M | -1.1% | +461.0% |
| Stockholders' Equity | -$18.6M | -27.3% | -315.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.1M | — | — |
| Capital Expenditures | $607K | — | — |
| Investing Cash Flow | $8.3M | — | — |
| Financing Cash Flow | $4.2M | — | — |
| Free Cash Flow | -$15.8M | — | — |